NRx Pharmaceuticals (NASDAQ:NRXP) Earns “Buy” Rating from D. Boral Capital
NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at D. Boral Capital in a report released on Friday,Benzinga reports. They presently have a $31.00 target price on the stock. A number of other research firms also recently weighed in on NRXP. Wall Street Zen upgraded NRx Pharmaceuticals […]
NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at D. Boral Capital in a report released on Friday,Benzinga reports. They presently have a $31.00 target price on the stock. A number of other research firms also recently weighed in on NRXP. Wall Street Zen upgraded NRx Pharmaceuticals […]
